Cargando…

AQP3‐mediated H(2)O(2) uptake inhibits LUAD autophagy by inactivating PTEN

It is widely accepted that redox reprogramming participates in malignant transformation of lung adenocarcinoma (LUAD). However, the source of excessive reactive oxygen species (ROS) and the downstream signaling regulatory mechanism are complicated and unintelligible. In the current study, we newly i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yawei, Chen, Di, Liu, Yu, Zhang, Yong, Duan, Chao, Otkur, Wuxiyar, Chen, Huan, Liu, Xiaolong, Xia, Tian, Qi, Huan, Piao, Hai‐long, Liu, Hong‐Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353907/
https://www.ncbi.nlm.nih.gov/pubmed/34091997
http://dx.doi.org/10.1111/cas.15008
Descripción
Sumario:It is widely accepted that redox reprogramming participates in malignant transformation of lung adenocarcinoma (LUAD). However, the source of excessive reactive oxygen species (ROS) and the downstream signaling regulatory mechanism are complicated and unintelligible. In the current study, we newly identified the aquaporin 3 (AQP3) as a LUAD oncogenic factor with capacity to transport exogenous hydrogen peroxide (H(2)O(2)) and increase intracellular ROS levels. Subsequently, we demonstrated that AQP3 was necessary for the facilitated diffusion of exogenous H(2)O(2) in LUAD cells and that the AQP3‐dependent transport of H(2)O(2) accelerated cell growth and inhibited rapamycin‐induced autophagy. Mechanistically, AQP3‐mediated H(2)O(2) uptake increased intracellular ROS levels to inactivate PTEN and activate the AKT/mTOR pathway to subsequently inhibit autophagy and promote proliferation in LUAD cells. Finally, we suggested that AQP3 depletion retarded subcutaneous tumorigenesis in vivo and simultaneously decreased ROS levels and promoted autophagy. These findings underscore the importance of AQP3‐induced oxidative stress in malignant transformation and suggest a therapeutic target for LUAD.